Springleaf Holdings Inc
MedReleaf’s Analyst Ratings and Price Target
The current consensus mean rating for MedReleaf stood at 1.6 with an overall “buy” recommendation on the stock for the next-12-month period.
Aurora Cannabis’s Price Target and Analyst Ratings
The current consensus mean price target on Aphria stood at 9.00 Canadian dollars, which is significantly below the company’s price of 11.50 Canadian dollars on February 6.
A Review of the Biggest Losers in the Cannabis Sector Last Week
With the increased perception of market risk, it’s natural that cannabis-related stocks also experienced a sell-off last week. Let’s look at this in more detail.
Why Scotts Miracle-Gro Stock Fell 14% on January 30
On Tuesday, January 30, 2018, Scotts Miracle-Gro (SMG) reported its 1Q18 earnings with a GAAP loss per share of $0.35. The stock took a significant beating and fell 14%.
Where Canadians Would Prefer to Buy Recreational Marijuana
In the previous part of this series, we briefly discussed how the different active components of the cannabis plant make it a more complex product than tobacco and alcohol.
Canopy Growth’s Recreational Marijuana Sales Channel
Canopy Growth stated that the Canadian provinces of Ontario and New Brunswick announced that the retail and distribution of recreational marijuana would be overseen by their liquor control boards.
How Canopy Growth Plans to Sell Recreational Marijuana
In Canopy Growth Corporation’s (WEED) filings, the company stated that it will invest in functions such as marketing, branding, and sales when regulated marijuana becomes legal in countries including Canada.
Considerations for Investors in Marijuana or Cryptocurrencies
The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.
Reputation Issues for Marijuana and Cryptocurrency
The cannabis industry has a cryptocurrency called PotCoin, which was created to provide an ecosystem to serve some of the needs of a cannabis-related business.
Why the Marijuana Wave May Not Be the Same as Cryptocurrency
In 2018, two investment waves set the market ablaze—marijuana and cryptocurrencies. Although cryptocurrencies have slid since early January, the marijuana wave has held up so far.
How Wall Street Is Taking an Interest in the Marijuana Industry
Marijuana is still classified as a Schedule 1 drug in the United States and is illicit under federal law. This has created several issues for businesses.
Retail sales and job openings loom large for real estate investors
The week after the jobs report is usually pretty data-light, and this week is no exception. The most important data will be the JOLTS and retail sales.